Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services.
Introduced First Reading Assembly Referred to AFI
Email me when A 5020 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 5020. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill stops PBMs from charging a higher price to insurers than they pay pharmacies, requiring them to pass 100% of rebates and discounts back to the plan. It also obligates PBMs to file detailed financial reports and audits, and mandates annual public disclosures. The goal is to lower drug costs for patients and increase transparency in the pharmacy benefits market.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 5020
3 free questions a day, no accountHistory
- Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Sponsors
- Peterpaul, Luanne M. · sponsor
- Peterpaul, Luanne M., Esq.
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 5020 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 5020 freeOr ask your AI assistant about A 5020 directly:
Add to Claude, ChatGPT or Cursor